Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System

Troy Watson; Jason Hickok; Sarah Fraker; Kimberly Korwek; Russell E. Poland; Edward Septimus

doi:10.1093/cid/cix1112

Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System

Troy Watson, Jason Hickok, Sarah Fraker, Kimberly Korwek, Russell E. Poland, Edward Septimus

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

In this multicenter retrospective cohort study of over 1 million patients at 150 US hospitals, proton pump inhibitors increased the odds of a patient having hospital-onset Clostridium difcile infection as did third and fourth generation cephalosporins, carbapenems, and piperacillin/tazobactam. Tese fndings support appropriate prescribing of acid-suppression therapy and high-risk antibiotics.

Original language	English (US)
Pages (from-to)	1957-1959
Number of pages	3
Journal	Clinical Infectious Diseases
Volume	66
Issue number	12
DOIs	https://doi.org/10.1093/cid/cix1112
State	Published - Jun 1 2018

Keywords

acid suppression medication
antibiotic therapy
Clostridium difcile infections
proton pump inhibitors
risk factors

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/cix1112

Cite this

@article{a2926060945040f0a15a149123f9d811,

title = "Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System",

abstract = "In this multicenter retrospective cohort study of over 1 million patients at 150 US hospitals, proton pump inhibitors increased the odds of a patient having hospital-onset Clostridium difcile infection as did third and fourth generation cephalosporins, carbapenems, and piperacillin/tazobactam. Tese fndings support appropriate prescribing of acid-suppression therapy and high-risk antibiotics.",

keywords = "acid suppression medication, antibiotic therapy, Clostridium difcile infections, proton pump inhibitors, risk factors",

author = "Troy Watson and Jason Hickok and Sarah Fraker and Kimberly Korwek and Poland, {Russell E.} and Edward Septimus",

note = "Publisher Copyright: {\textcopyright} 2017 The Author(s).",

year = "2018",

month = jun,

day = "1",

doi = "10.1093/cid/cix1112",

language = "English (US)",

volume = "66",

pages = "1957--1959",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System

AU - Watson, Troy

AU - Hickok, Jason

AU - Fraker, Sarah

AU - Korwek, Kimberly

AU - Poland, Russell E.

AU - Septimus, Edward

PY - 2018/6/1

Y1 - 2018/6/1

N2 - In this multicenter retrospective cohort study of over 1 million patients at 150 US hospitals, proton pump inhibitors increased the odds of a patient having hospital-onset Clostridium difcile infection as did third and fourth generation cephalosporins, carbapenems, and piperacillin/tazobactam. Tese fndings support appropriate prescribing of acid-suppression therapy and high-risk antibiotics.

AB - In this multicenter retrospective cohort study of over 1 million patients at 150 US hospitals, proton pump inhibitors increased the odds of a patient having hospital-onset Clostridium difcile infection as did third and fourth generation cephalosporins, carbapenems, and piperacillin/tazobactam. Tese fndings support appropriate prescribing of acid-suppression therapy and high-risk antibiotics.

KW - acid suppression medication

KW - antibiotic therapy

KW - Clostridium difcile infections

KW - proton pump inhibitors

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=85047983709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047983709&partnerID=8YFLogxK

U2 - 10.1093/cid/cix1112

DO - 10.1093/cid/cix1112

M3 - Article

C2 - 29272341

AN - SCOPUS:85047983709

VL - 66

SP - 1957

EP - 1959

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 12

ER -

Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this